LAKE FOREST, Ill., April 22, 2014 /PRNewswire/ -- Hospira, Inc.
(NYSE: HSP), the world's leading provider of injectable drugs and
infusion technologies, today announced that the company will
present at three upcoming conferences:
- Bank of America Merrill Lynch 2014 Health Care
Conference
May 14, 2014 (Wednesday) – Las
Vegas
10:00 a.m. Pacific time
- UBS Global Healthcare Conference
May 20, 2014 (Tuesday)
11:30 a.m. Eastern time
- Sanford C. Bernstein's 30th
Annual Strategic Decisions Conference
May 29, 2014 (Thursday) – New York
8:00 a.m. Eastern time
The presentations will be available to all interested parties
through a live audiocast accessible via the investor relations
section of Hospira's website at www.hospirainvestor.com. Listeners
should log on approximately 10 minutes in advance to ensure proper
setup to receive the audiocast. Any accompanying slides will be
available on the Hospira website. A replay of the webcast will be
available on the Hospira website approximately 24 hours after the
live presentation for 30 days after the event.
About Hospira
Hospira, Inc., is the world's leading provider of injectable
drugs and infusion technologies, and a global leader in
biosimilars. Through its broad, integrated portfolio, Hospira is
uniquely positioned to Advance Wellness™ by improving patient and
caregiver safety while reducing healthcare costs. The company is
headquartered in Lake Forest,
Ill., and has approximately 17,000 employees. Learn more at
www.hospira.com.
SOURCE Hospira, Inc.